Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention Jonathan R. Davis, Editor; Based on a Workshop of the Forum on Emerging Infections, Institute of Medicine This workshop summary report from the IOM Forum on Emerging Infections, Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strenghening Surveillance, Research and Prevention This book examines how the managed care revolution has created both problems and opportunities in the fight against infectious diseases. It highlights ways in which managed care systems can aid research, develop clinical guidelines, manage the use of antibiotics, support public education efforts, and monitor the spread of emerging infections and microbial resistance.
Jonathan R. Davis, Editor; Based on a Workshop of the Forum on Emerging Infections, Institute of Medicine
1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Conducting Basic and Clinical Research in the Managed Care Setting; 5 3 Clinical Practice Guidelines; 6 4 Surveillance and Monitoring; 7 5 Education and Outreach; 8 6 Drug Formularies; 9 7 Concluding Remarks; 10 References; 11 Appendix A: Veterans Health Administration and Infectious Disease; 12 Appendix B: Glossary and Acronyms; 13 Appendix C: Workshop Agenda; 14 Appendix D: Forum Member and Staff Biographies
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Division of Health Sciences Policy, and Medical Devices Roundtable on Research and Development of Drugs, Biologics, Jonathan R. Davis, Sarah Pitluck, Peter Bouxsein, Ronald W. Estabrook, M.D. Yaffe, Sumner
Institute of Medicine, and Medical Devices Roundtable on Research and Development of Drugs, Biologics, Ronald W. Estabrook, Janet Woodcock, Vivian P. Nolan, Jonathan R. Davis